- Home
- BFIN vs AARD Comparison
BFIN vs AARD Comparison
Compare BFIN & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFIN
- AARD
- Stock Information
- Founded
- BFIN 1924
- AARD 2017
- Country
- BFIN United States
- AARD United States
- Employees
- BFIN N/A
- AARD N/A
- Industry
- BFIN Savings Institutions
- AARD Biotechnology: Pharmaceutical Preparations
- Sector
- BFIN Finance
- AARD Health Care
- Exchange
- BFIN Nasdaq
- AARD Nasdaq
- Market Cap
- BFIN 153.0M
- AARD 154.9M
- IPO Year
- BFIN N/A
- AARD 2025
- Fundamental
- Price
- BFIN $12.04
- AARD $10.44
- Analyst Decision
- BFIN
- AARD Strong Buy
- Analyst Count
- BFIN 0
- AARD 4
- Target Price
- BFIN N/A
- AARD $31.25
- AVG Volume (30 Days)
- BFIN 18.1K
- AARD 50.1K
- Earning Date
- BFIN 07-30-2025
- AARD 05-14-2025
- Dividend Yield
- BFIN 3.32%
- AARD N/A
- EPS Growth
- BFIN N/A
- AARD N/A
- EPS
- BFIN 0.36
- AARD N/A
- Revenue
- BFIN $48,547,000.00
- AARD N/A
- Revenue This Year
- BFIN $1.43
- AARD N/A
- Revenue Next Year
- BFIN $4.33
- AARD N/A
- P/E Ratio
- BFIN $33.76
- AARD N/A
- Revenue Growth
- BFIN N/A
- AARD N/A
- 52 Week Low
- BFIN $9.71
- AARD $4.88
- 52 Week High
- BFIN $13.97
- AARD $19.58
- Technical
- Relative Strength Index (RSI)
- BFIN 47.40
- AARD N/A
- Support Level
- BFIN $11.86
- AARD N/A
- Resistance Level
- BFIN $12.22
- AARD N/A
- Average True Range (ATR)
- BFIN 0.26
- AARD 0.00
- MACD
- BFIN 0.01
- AARD 0.00
- Stochastic Oscillator
- BFIN 33.33
- AARD 0.00
About BFIN BankFinancial Corporation
BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.